What do systematic reviews say?

Oat‐containing moisturisers vs vehicle or no moisturiser

• Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 226 participants
  Low

Moisturisers vs vehicle, placebo or no moisturiser

• Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 300 participants
  Low

Topical active treatment in combination with moisturiser vs topical active treatment alone

• Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 67 participants
  Low

Moisturisers vs no treatment (no moisturiser)

• Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 177 participants
  Low

Selenium (+LT4) vs placebo (+LT4)

The review found no eligible studies for this question.

• Selenium supplementation for Hashimoto's thyroiditis 2013 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Cannabis vs placebo

• Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis 2022 · Cochrane Headline outcomes only
  no estimate extracted
  8 studies · 1942 participants
  Low

Atopiclair vs vehicle

The review found no eligible studies for this question.

• Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Urea‐containing moisturisers vs vehicle, placebo or no moisturiser

The review found no eligible studies for this question.

• Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Glycerin/glycerol‐containing moisturisers vs vehicle or placebo

The review found no eligible studies for this question.

• Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

ICS dose reduction vs no change

• Stepping down the dose of inhaled corticosteroids for adults with asthma 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 554 participants
  Very low

Ataluren vs placebo

• Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 506 participants
  High

Etanercept vs placebo

• Anti‐TNF agents for paediatric psoriasis 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 211 participants
  Moderate